| Literature DB >> 25561460 |
Markus Høybye Bosteen1, Björn Dahlbäck2, Lars Bo Nielsen1, Christina Christoffersen1.
Abstract
apoM is a member of the lipocalin superfamily and circulates in plasma attached to HDL particles. apoM plays a role in cholesterol metabolism and has recently been identified as transporter for the signaling lipid, sphingosine-1-phosphate (S1P), in plasma. S1P is implicated in several inflammatory diseases such as multiple sclerosis and rheumatoid arthritis. The ability to accurately measure apoM is crucial for investigating its biological functions and possible clinical implications. However, reliable commercial methods have been lacking so far. Therefore, we have developed an assay that specifically recognizes human apoM in plasma using commercially available reagents. Commercial apoM antibodies were screened for compatibility in a sandwich ELISA-based assay. One optimal pair of antibodies was chosen, and sample preparation, buffers, and incubation times were optimized to generate a simple and reproducible method. Validation and comparison to a previously described ELISA for apoM confirmed that the assay displays a high degree of sensitivity, specificity, and precision. Our results show that commercially available antibodies can be used to accurately measure human plasma apoM. This method can be implemented in every laboratory and will help promote high quality research.Entities:
Keywords: antibodies; cholesterol; enzyme-linked immunosorbent assay; high density lipoprotein; lipoproteins; sphingosine phosphate
Mesh:
Substances:
Year: 2015 PMID: 25561460 PMCID: PMC4340322 DOI: 10.1194/jlr.D055947
Source DB: PubMed Journal: J Lipid Res ISSN: 0022-2275 Impact factor: 5.922